Results 1 to 10 of about 133,065 (120)

Does perioperative allogeneic blood transfusion worsen the prognosis of patients with hepatocellular carcinoma? A meta-analysis of propensity score-matched studies

Frontiers in Oncology, 2023
BackgroundAllogeneic blood transfusion is required in a part of liver resection. The effect of allogeneic blood transfusion on the prognosis of patients with hepatocellular carcinoma (HCC) remains controversial.
Lingbo Hu, Lingbo Hu, Zhenyu Li, Zhenyu Li, Yingli Qiao, Yingli Qiao, Aidong Wang, Aidong Wang   +7 more
doaj   +1 more source

Survival Rates of Dental Implants in Autogenous and Allogeneic Bone Blocks: A Systematic Review

Medicina, 2021
Background and Objectives: Preliminary studies emphasize the similar performance of autogenous bone blocks (AUBBs) and allogeneic bone blocks (ALBBs) in pre-implant surgery; however, most of these studies include limited subjects or hold a low level of ...
Phil Donkiewicz, Korbinian Benz, Anita Kloss-Brandstätter, Jochen Jackowski   +3 more
doaj   +1 more source

Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy

Pharmaceutics, 2021
The use of allogeneic adipose-derived mesenchymal stromal cells (alloADSCs) represents an attractive approach for treating myocardial infarction (MI).
Ascensión López-Díaz de Cerio, Iñigo Perez-Estenaga, Susana Inoges, Gloria Abizanda, Juan José Gavira, Eduardo Larequi, Enrique Andreu, Saray Rodriguez, Ana Gloria Gil, Verónica Crisostomo, Francisco Miguel Sanchez-Margallo, Javier Bermejo, Blanca Jauregui, Lluis Quintana, Francisco Fernández-Avilés, Beatriz Pelacho, Felipe Prósper   +16 more
doaj   +1 more source

Human Vδ2 T Cells and Their Versatility for Immunotherapeutic Approaches

Cells, 2022
Gamma/delta (γδ) T cells are innate-like immune effectors that are a critical component linking innate and adaptive immune responses. They are recognized for their contribution to tumor surveillance and fight against infectious diseases.
Marta Sanz, Brendan T. Mann, Alisha Chitrakar, Natalia Soriano-Sarabia   +3 more
doaj   +1 more source

Treatment of osteoarthritis with autologous and allogeneic expanded bone marrow mesenchymal stem cells [PDF]

CellR4, 2021
In this review we explore the past, present and future treatment of osteoarthritis using autologous and allogeneic bone marrow mesenchymal stem cells (MSCs). Osteoarthritis is one of the most prevalent joint diseases worldwide.
P. Hollands, D. Porter
doaj   +1 more source

Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant

Haematologica, 2013
Delayed immune recovery is a characteristic feature of allogeneic hematopoietic stem cell transplantation in adult recipients. Although recipient thymic T-cell neogenesis contributes to T-cell regeneration after transplantation, thymic recovery in the ...
Zachariah McIver, Jan Joseph Melenhorst, Colin Wu, Andrew Grim, Sawa Ito, Irene Cho, Nancy Hensel, Minoo Battiwalla, Austin John Barrett   +8 more
doaj   +1 more source

HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy

Frontiers in Immunology, 2021
Cellular immunotherapy using chimeric antigen receptors (CARs) so far has almost exclusively used autologous peripheral blood-derived T cells as immune effector cells.
Keven Hoerster, Markus Uhrberg, Constanze Wiek, Peter A. Horn, Peter A. Horn, Helmut Hanenberg, Helmut Hanenberg, Stefan Heinrichs, Stefan Heinrichs   +8 more
doaj   +1 more source

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation

Haematologica, 2016
Improvement of graft-versus-host disease prophylaxis remains an important goal in allogeneic hematopoietic stem cell transplantation. Based on reports of possibly preferential properties of sirolimus, we compared the standard regimen of cyclosporine and ...
Johan Törlén, Olle Ringdén, Karin Garming-Legert, Per Ljungman, Jacek Winiarski, Kari Remes, Maija Itälä-Remes, Mats Remberger, Jonas Mattsson   +8 more
doaj   +1 more source

Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Journal of Immunology Research, 2016
Background. Graft-versus-host disease (GVHD) is a serious complication after allogeneic hematopoietic stem cell transplantation (HSCT). We designed a functional assay for assessment of individual risk for acute GVHD. Study Design and Methods.
Darius Sairafi, Arwen Stikvoort, Jens Gertow, Jonas Mattsson, Michael Uhlin   +4 more
doaj   +1 more source

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts

CNS Oncology, 2018
Aim: ERC1671 is an allogeneic/autologous therapeutic glioblastoma (GBM) vaccine – composed of whole, inactivated tumor cells mixed with tumor cell lysates derived from the patient and three GBM donors.
Daniela A Bota, Jinah Chung, Manisha Dandekar, Jose A Carrillo, Xiao-Tang Kong, Beverly D Fu, Frank PK Hsu, Axel H Schönthal, Florence M Hofman, Thomas C Chen, Raphael Zidovetzki, Chrystel Pretto, Ankie Strik, Virgil EJC Schijns, Apostolos Stathopoulos   +14 more
doaj   +1 more source